Related Experiment Videos
Targeting p53 in cancer
1Novartis, Oncology Department, Basel CH-4002, Switzerland. patrick_chene@yahoo.com
Current Medicinal Chemistry. Anti-Cancer Agents
|April 8, 2003
Summary
Loss of p53 function accelerates cancer development and impacts treatment efficacy. Research focuses on targeting altered p53 pathways using biological and chemical strategies to improve cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Loss of p53 function is a critical event in cancer development.
- Altered p53 influences the effectiveness of chemotherapy and radiotherapy.
- The p53 pathway is a key target for anti-cancer drug development.
Purpose of the Study:
- To review current progress in strategies targeting tumors with altered p53.
- To analyze biological and chemical approaches for p53-targeted cancer therapy.
Main Methods:
- Review of current academic and industrial research on p53.
- Categorization of strategies into biological and chemical approaches.
- Analysis of specific therapeutic tactics within each strategy.
Main Results:
- Biological strategies involve immunotherapy, gene therapy, and oncolytic viruses.
- Chemical strategies focus on stabilizing/activating p53 mutants, inhibiting p53-hdm2 interactions, or targeting chaperones.
- Diverse approaches are under investigation to exploit p53 alterations in cancer.
Conclusions:
- Targeting the p53 pathway offers promising avenues for novel cancer treatments.
- Both biological and chemical strategies present distinct but potentially synergistic therapeutic opportunities.
- Continued research is essential to translate these strategies into effective clinical applications.